Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Pozzilli

Showing results (91-100 of 264) with videos related to

Pageof 27
Sort By:
Diabetes/Metabolism Research and Reviews|April 6, 2024
LADA 30th anniversary: A growing form of diabetes with persistent unresolved questionsIvy Lee Jia Jia, Raffaella Buzzetti, Richard David Leslie, et al.
Diabetes/Metabolism Research and Reviews|January 21, 2016
Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonistsFrancesco Giorgino, Riccardo C Bonadonna, Sandro Gentile, et al.
Fertility and Sterility|January 15, 2008
Menarche in type 1 diabetes is still delayed despite good metabolic controlAntonio Picardi, Elisa Cipponeri, Carla Bizzarri, et al.
Current Pharmaceutical Design|August 26, 2011
Clinical update on the use of immuno modulators (antiCD3, GAD, Diapep277, anti-IL1) in type 1 diabetesPaolo Pozzilli, Chiara Guglielmi, Daria Maggi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2010
Evolution of ectopic lymphoid neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic isletsElisa Astorri, Michele Bombardieri, Silvia Gabba, et al.
Diabetes Care|June 7, 2020
Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data From People With Diabetes on Intensive Insulin TherapyErnesto Maddaloni, Lucia Coraggio, Silvia Pieralice, et al.
Artificial Organs|August 31, 2017
A Novel Three-Compartmental Model for Artificial Pancreas: Development and ValidationVincenzo Piemonte, Mauro Capocelli, Luca De Santis, et al.
Diabetologia|May 21, 2017
Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in childrenRocky Strollo, Chiara Vinci, Nicola Napoli, et al.
Human Immunology|June 1, 2002
beta-cell antigen-specific CD56(+) NKT cells from type 1 diabetic patients: autoaggressive effector T cells damage human CD56(+) beta cells by HLA-restricted and non-HLA-restricted pathwaysDawei Ou, Daniel L Metzger, Xiaojie Wang, et al.
Diabetes Research and Clinical Practice|September 18, 2020
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deathsRocky Strollo, Ernesto Maddaloni, Marco Dauriz, et al.
Pageof 27

Showing results (91-100 of 264) with videos related to

Sort By:
Pageof 27
Diabetes/Metabolism Research and Reviews|April 6, 2024
LADA 30th anniversary: A growing form of diabetes with persistent unresolved questionsIvy Lee Jia Jia, Raffaella Buzzetti, Richard David Leslie, et al.
Diabetes/Metabolism Research and Reviews|January 21, 2016
Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonistsFrancesco Giorgino, Riccardo C Bonadonna, Sandro Gentile, et al.
Fertility and Sterility|January 15, 2008
Menarche in type 1 diabetes is still delayed despite good metabolic controlAntonio Picardi, Elisa Cipponeri, Carla Bizzarri, et al.
Current Pharmaceutical Design|August 26, 2011
Clinical update on the use of immuno modulators (antiCD3, GAD, Diapep277, anti-IL1) in type 1 diabetesPaolo Pozzilli, Chiara Guglielmi, Daria Maggi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2010
Evolution of ectopic lymphoid neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic isletsElisa Astorri, Michele Bombardieri, Silvia Gabba, et al.
Diabetes Care|June 7, 2020
Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data From People With Diabetes on Intensive Insulin TherapyErnesto Maddaloni, Lucia Coraggio, Silvia Pieralice, et al.
Artificial Organs|August 31, 2017
A Novel Three-Compartmental Model for Artificial Pancreas: Development and ValidationVincenzo Piemonte, Mauro Capocelli, Luca De Santis, et al.
Diabetologia|May 21, 2017
Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in childrenRocky Strollo, Chiara Vinci, Nicola Napoli, et al.
Human Immunology|June 1, 2002
beta-cell antigen-specific CD56(+) NKT cells from type 1 diabetic patients: autoaggressive effector T cells damage human CD56(+) beta cells by HLA-restricted and non-HLA-restricted pathwaysDawei Ou, Daniel L Metzger, Xiaojie Wang, et al.
Diabetes Research and Clinical Practice|September 18, 2020
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deathsRocky Strollo, Ernesto Maddaloni, Marco Dauriz, et al.
Pageof 27